Table of Contents
What changed
The headline NPAT swung from a NZD212.2m loss in HY25 to a NZD605.7m profit in HY26, but two non-recurring forces dominate that reversal. First, a NZD280.2m after-tax gain from discontinued operations appeared in HY26 where there was nothing in HY25. Second, continuing-operations PBT moved from a NZD128.6m loss to a NZD327.7m profit — a genuine improvement, but substantially driven by associates equity earnings of NZD525.9m versus NZD107.0m in HY25, a line that is itself partly fair-value-driven.
Revenue on the face of the income statement fell 15.7% to NZD1,446.1m. The primary driver is Manawa Energy, whose disclosed segment revenue collapsed from NZD305.2m to NZD125.5m — likely reflecting both hydrology and the partial disposal process rather than underlying demand destruction. One NZ, the largest segment at roughly 57% of disclosed revenue, held largely flat at NZD953.8m while swinging its operating surplus from a NZD50.0m loss to a NZD69.1m gain. The two medical imaging businesses (Qscan and RHCNZ Medical Imaging) grew modestly in revenue and together contributed NZD72.6m in operating surplus versus NZD20.2m in HY25.
On the balance sheet, gross borrowings fell sharply from NZD5,136m to NZD3,602m, reducing calculated net debt from roughly NZD4,640m to NZD3,381m — a meaningful deleveraging. Cash on hand, however, fell from NZD496.3m to NZD220.5m.
What matters
One NZ's operating surplus reversal is the most consequential ongoing development. A NZD119m swing from a loss to a gain in a segment that generates more than half the group's disclosed revenue changes the quality read on the portfolio materially. The release notes above-target performance for One NZ despite challenging NZ telco conditions. Whether this reflects structural cost discipline, one-off items, or a favourable repricing cycle is not clearly separated in the available data.
Cash conversion has deteriorated sharply and warrants scrutiny. Operating cash flow fell from NZD93.1m to NZD32.7m while capex increased from NZD207.9m to NZD250.2m, deepening the pre-lease free cash flow deficit from NZD114.8m to NZD217.5m. The dividend is not covered by free cash flow. The FY25 full-year pattern showed operating cash flow strongly back-weighted (HY25 contributed only 24.1% of the full-year total), so there may be a seasonal explanation — but the divergence between reported profit and cash generation is stark enough to demand explanation.
The NZD280.2m discontinued-operations gain inflates reported NPAT and should be excluded from any run-rate assessment. Continuing-operations profit of NZD351.3m is the more useful figure, and even that is heavily influenced by the associates line (NZD525.9m), which itself requires scrutiny for fair-value content.
Expectations
No explicit quantitative targets for HY26 were disclosed in the filing excerpts provided. The prior full-year EBITDAF anchor was NZD986m, described as towards the upper end of guidance of NZD960–1,000m for FY25. The release states proportionate operational EBITDAF grew to NZD514m in HY26, which annualises to approximately NZD1,028m — suggestive of continuation above the FY25 level if the second half holds.
The FY25 revenue pattern was roughly balanced (HY25 contributed 51.3% of the full-year total), so there is no strong historical basis for assuming a materially larger second half on revenue. The NPAT pattern was heavily first-half-weighted in FY25 given the prior year's loss dynamics, making year-on-year NPAT comparison for HY26 vs HY25 less informative than the EBITDAF trend.
No forward order book or revenue visibility metrics were disclosed in the available excerpts.
Quality of result
The result contains several layers that reduce its apparent quality when examined against cash generation:
- The NZD280.2m discontinued-operations gain is by definition non-recurring and accounts for 46% of reported NPAT.
- The associates line of NZD525.9m — which drives most of the continuing-operations PBT — is equity-accounted and likely contains unrealised revaluation movements. Without a reconciliation to EBITDAF, the cash backing of this contribution cannot be verified from available data.
- Operating cash flow of NZD32.7m against a NZD605.7m NPAT implies an effective cash conversion rate of roughly 5%, which is very low even acknowledging the non-cash nature of the associates and discontinued-operations items.
- One NZ's reversal to profitability and the medical imaging businesses' improved contributions look operationally durable, but they represent a minority of reported NPAT.
- The EBITDAF metric of NZD514m, if taken as the cleanest operational proxy, is a more credible earnings quality indicator than NPAT, though no full GAAP reconciliation was available.
Unresolved
- What is the fair-value content within the NZD525.9m associates contribution, and how much of it is cash-generative versus revaluation uplift?
- What caused the NZD60.4m collapse in operating cash flow — working capital timing, changes in associate cash distributions, or underlying operating deterioration?
- Is One NZ's swing to profitability structural (cost resets, repricing) or partly a function of one-off items or timing of network investment charges?
- Which entity or transaction accounts for the NZD280.2m discontinued-operations gain, and are there further disposal proceeds expected?
- Gross borrowings fell by NZD1,534m — was this funded by disposal proceeds, and does this leave the balance sheet adequately capitalised for the stated growth pipeline in renewables and data infrastructure?
This briefing cannot assess the intrinsic valuation of Infratil's portfolio or the fair-value assumptions embedded in the associates and discontinued-operations lines without access to the underlying investment valuation schedules.
Key metrics
| Metric | HY26 | HY25 | Change |
|---|---|---|---|
| Revenue | $1.4m | $1.7m | -15.7% ↓ |
| Net profit after tax | $605.7m | −$212.2m | +385.4% ↑ |
| Net cash inflow from operating activities | $32.7m | $93.1m | -64.9% ↓ |
| Interim dividend per share | 7.2c | 7.2c | flat |
| Operating profit | $662.4m | $136.4m | +385.6% ↑ |
| Profit before tax | $327.7m | −$128.6m | +354.8% ↑ |
| Cash and cash equivalents | $220.5m | $496.3m | -55.6% ↓ |
| Total assets | $16.8m | $16.1m | +4.3% ↑ |
Source: annolyse.ai/briefings/ift-hy26
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Gurīn Energy Asia | $5m | −$0.3m | −$13.1m | n/a |
| Manawa Energy New Zealand | $125.5m | $305.2m | $1.1m | -10.4pp |
| Mint Renewables Australasia | $0.1m | $0m | −$8.6m | n/a |
| Wellington International Airport New Zealand | $94.4m | $90.9m | −$5.4m | +0.3pp |
| Qscan Group Australia | $187.5m | $176m | $26.7m | +0.9pp |
| RHCNZ Medical Imaging New Zealand | $194m | $190.7m | $45.9m | +0.4pp |
| One NZ New Zealand | $953.8m | $939.6m | $69.1m | +1.9pp |
| Associates | — | — | $525.9m | n/a |
| All other segments and corporate New Zealand | $109.2m | $0.2m | −$33.6m | +6.5pp |
Source: annolyse.ai/briefings/ift-hy26
Analytical metrics
| Metric | HY26 | HY25 | Context |
|---|---|---|---|
| Effective tax rate | -7.2% | n/m (loss period) | prior loss period |
| FCF pre-lease | −$217.5m | −$114.8m | −$102.7m |
| FCF / NPAT | -35.9% | 54.1% | complementary conversion metric |
| Capex % revenue | n/m | n/m | — |
| Capex | −$250.2m | −$207.9m | −$42.3m |
| Inventory days | 5958.9 | 3871.7 | +2087.2 days |
| Net debt | $3381.3m | $4640.0m | −$1258.7m |
| Gross borrowings | $3.6m | $5.1m | −$1.5m |
| Payout ratio vs NPAT | 11.7% | — | — |
| ROE (annualised) | 7.3% | -2.6% | Strengthening |
| HY25 share of FY25 revenue | 51.3% | — | Other half was 48.7% |
| HY25 share of FY25 NPAT | 74.1% | — | Other half was 25.9% |
| Profit from continuing operations | $351.3m | −$206.4m | +$557.7m |
| Discontinued operation after tax | $280.2m | $0.0m | +$280.2m |
Source: annolyse.ai/briefings/ift-hy26
This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX/ASX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.